
IDEXX Laboratories IDXX
€ 465.90
-4.04%
Geschäftsbericht 2025
hinzugefügt 20.02.2026
IDEXX Laboratories P/CF 2011-2026 | IDXX
P/CF Jährlich IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.3 | 40.5 | 52.3 | 78.8 | 60 | 68.5 | 80.4 | 65.1 | 55.2 | 40.1 | 48.7 | 45.3 | 36.1 | 32.3 | 28.8 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 80.4 | 28.8 | 51.7 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 110.54 | -3.78 % | $ 33.6 B | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 23.48 | -4.96 % | $ 652 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.14 | -2.14 % | $ 1.98 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.54 | -5.52 % | $ 2.05 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 25.75 | -5.1 % | $ 20 B | ||
|
Personalis
PSNL
|
-5.62 | $ 4.99 | -9.27 % | $ 296 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 18.4 | -16.02 % | $ 980 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 14.63 | -4.38 % | $ 442 M | ||
|
Illumina
ILMN
|
19.6 | $ 119.48 | -5.86 % | $ 19 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 163.57 | -1.93 % | $ 8.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.61 | -0.64 % | $ 61.9 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 56.5 | -4.48 % | $ 3.38 B | ||
|
Guardant Health
GH
|
-72.7 | $ 80.29 | -3.4 % | $ 10.1 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 80.55 | -3.59 % | $ 5.44 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.43 | -10.44 % | $ 268 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 410.99 | 0.3 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.16 | -0.77 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 118.78 | 15.89 % | $ 9.8 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 255.46 | -1.57 % | $ 21.3 B | ||
|
NeoGenomics
NEO
|
284 | $ 8.36 | -7.37 % | $ 1.07 B | ||
|
Celcuity
CELC
|
-35 | $ 117.64 | -2.03 % | $ 5.5 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 16.08 | -4.54 % | $ 360 M | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.63 | -4.44 % | $ 429 M | ||
|
Natera
NTRA
|
-12.3 | $ 190.92 | -4.62 % | $ 18.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 189.71 | -2.74 % | $ 21.1 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.12 | -3.18 % | $ 173 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M |